Clearside Biomedical (NASDAQ:CLSD) named Dr. Richard Beckman, a board certified ophthalmologist, as chief medical officer.
Dr. Beckman brings 13 years of clinical practice experience and over 20 years of corporate executive and consultancy experience within the global ophthalmic industry to Clearside.
Prior to joining Clearside, Dr. Beckman managed a successful pharmaceutical and medical device industry-consulting firm that served a broad range of companies. Previously, he was CMO and general manager of the Ocular and Novel Drug Delivery Systems business unit at Unilife.
“In addition to being a skilled physician, Rick is a seasoned corporate leader with a strong track record of delivering medical, scientific and strategic guidance to both large and emerging ophthalmic companies,” Clearside president and CEO, Daniel White, said in a statement.
“Richard will provide a strong liaison with both industry and clinicians and first and foremost ensure our clinical programs are designed to meet the needs of both clinicians and patients,” he added.